Use access key #2 to skip to page content.
$46.09 -0.16 (-0.35%)
7/23/2008 4:03 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
***

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar pfxlovell (86.31) Submitted: 3/16/07 3:41 PM : Outperform Start Price: $53.26 AZN Score: -5.95

Looking to acquire biotechs to enhance pipeline. Solid company - great management.

Report this Post Replies: 0 | Reply

Featured Broker Partners